Figure 2From: Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG123I-MIBG ( a ) and 111In-pentetreotide ( b ) scans before MIBG therapy no. 9, followed by the post-therapeutic 131I-MIBG scan ( c ): Later stage metastases to the lungs, liver, lymph nodes, soft tissue and bone, still displaying avid tracer uptake. The 111In-pentetreotide scan shows no additional lesions compared to the MIBG scans.Back to article page